[go: up one dir, main page]

NO943511D0 - Farmasöytiske preparater og anvendelse derav - Google Patents

Farmasöytiske preparater og anvendelse derav

Info

Publication number
NO943511D0
NO943511D0 NO943511A NO943511A NO943511D0 NO 943511 D0 NO943511 D0 NO 943511D0 NO 943511 A NO943511 A NO 943511A NO 943511 A NO943511 A NO 943511A NO 943511 D0 NO943511 D0 NO 943511D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NO943511A
Other languages
English (en)
Other versions
NO943511L (no
NO306235B1 (no
Inventor
Ronald Brown Miller
Allan John Miller
Stephen Gordon Douglas
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO943511D0 publication Critical patent/NO943511D0/no
Publication of NO943511L publication Critical patent/NO943511L/no
Publication of NO306235B1 publication Critical patent/NO306235B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO943511A 1993-09-22 1994-09-21 Anvendelse av et legemiddel for behandling av artritt NO306235B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939319568A GB9319568D0 (en) 1993-09-22 1993-09-22 Pharmaceutical compositions and usages

Publications (3)

Publication Number Publication Date
NO943511D0 true NO943511D0 (no) 1994-09-21
NO943511L NO943511L (no) 1995-03-23
NO306235B1 NO306235B1 (no) 1999-10-11

Family

ID=10742359

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943511A NO306235B1 (no) 1993-09-22 1994-09-21 Anvendelse av et legemiddel for behandling av artritt

Country Status (10)

Country Link
US (2) US5763452A (no)
EP (1) EP0649657A1 (no)
JP (1) JPH07330628A (no)
CN (1) CN1078071C (no)
AU (1) AU7414694A (no)
CA (1) CA2132568A1 (no)
GB (1) GB9319568D0 (no)
IL (1) IL111044A (no)
NO (1) NO306235B1 (no)
ZA (1) ZA947305B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
RU2241458C2 (ru) * 1997-12-22 2004-12-10 Эро-Селтик, С.А. Комбинации агонист/антагонист опиоида
US6228863B1 (en) * 1997-12-22 2001-05-08 Euro-Celtique S.A. Method of preventing abuse of opioid dosage forms
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
NZ511442A (en) * 1998-11-02 2003-02-28 Elan Corp Plc Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
DK2092936T3 (da) * 2000-02-08 2013-06-17 Euro Celtique Sa Orale opioid-agonist-formuleringer sikret mod forfalskning
ES2361148T3 (es) 2001-05-11 2011-06-14 Endo Pharmaceuticals Inc. Forma de dosificación de opioides de liberación controlada resistente al abuso.
SI1416842T1 (sl) * 2001-07-18 2009-06-30 Euro Celtique Sa Farmacevtske kombinacije oksikodona in naloksona
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
PT1414451E (pt) 2001-08-06 2009-07-31 Euro Celtique Sa Formulações agonistas de opióides com antagonista libertável e sequestrado
KR20030060730A (ko) * 2002-01-09 2003-07-16 하나제약 주식회사 난용성 약물의 서방화 제제 조성물
DE20321531U1 (de) 2002-04-05 2007-11-22 Euro-Celtique S.A. Lagerstabiles pharmazeutisches Präparat, das Oxycodon und Naloxon umfaßt
DE60318041T2 (de) * 2002-05-16 2008-11-27 N.V. Organon Synergetische Kombination eines Opiatanalgetikums und eines NSAID's
SI1551372T1 (en) 2002-09-20 2018-08-31 Alpharma Pharmaceuticals Llc SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) * 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
SE0301880D0 (sv) * 2003-06-25 2003-06-25 Astrazeneca Uk Ltd New drug delivery composition
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
WO2006125616A2 (en) * 2005-05-25 2006-11-30 Ingenium Pharmaceuticals Ag Pyrimidine-based cdk inhibitors for treating pain
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
JP2009535409A (ja) * 2006-05-03 2009-10-01 コーワ ファーマシューティカルズ アメリカ，インコーポレイティド 即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬
EP1859771A1 (en) * 2006-05-24 2007-11-28 Guardant S.r.l. Low-compatible active principles in bipartite bag
KR20150029762A (ko) 2006-06-19 2015-03-18 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
US20080075771A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophilic opioid abuse deterrent delivery system using opioid antagonists
GB0625646D0 (en) * 2006-12-21 2007-01-31 Jagotec Ag Improvements in or relating to organic compounds
WO2008115820A1 (en) * 2007-03-16 2008-09-25 Elan Corporation Plc Combination of a narcotic and a non-narcotic analgesic
US8389521B2 (en) * 2007-04-24 2013-03-05 Ingenium Pharmaceuticals Gmbh Inhibitors of protein kinases
JP5566880B2 (ja) 2007-04-24 2014-08-06 インゲニウム ファーマシューティカルズ ジーエムビーエイチ プロテインキナーゼの阻害剤としての４，６−二置換アミノピリミジン誘導体
US8436007B2 (en) * 2007-04-24 2013-05-07 Ingenium Pharmaceuticals Gmbh Inhibitors of protein kinases
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8362029B2 (en) 2008-12-31 2013-01-29 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
US9271940B2 (en) 2009-03-10 2016-03-01 Purdue Pharma L.P. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
BR112012008317A2 (pt) 2009-09-17 2016-03-22 Upsher Smith Lab Inc produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
MX2016000810A (es) 2013-07-23 2016-08-05 Euro Celtique Sa Combinacion de oxicodona y naloxona para su uso en el tratamiento de dolor en pacientes que sufren de dolor y una enfermedad que resulta la disbiosis intestinal y/o aumento del riesgo de la translocacion bacteriana intestinal.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012513A (en) * 1971-11-03 1977-03-15 Imperial Chemical Industries Limited Indole derivatives for providing analgesic and anti-inflammatory effects
US4183941A (en) * 1978-08-21 1980-01-15 John R. A. Simoons Treatment of rheumatoid arthritis and related diseases
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
IL111044A (en) 1998-12-06
AU7414694A (en) 1995-04-06
GB9319568D0 (en) 1993-11-10
JPH07330628A (ja) 1995-12-19
IL111044A0 (en) 1994-12-29
CN1108934A (zh) 1995-09-27
ZA947305B (en) 1995-05-10
US5908848A (en) 1999-06-01
EP0649657A1 (en) 1995-04-26
CA2132568A1 (en) 1995-03-23
NO943511L (no) 1995-03-23
CN1078071C (zh) 2002-01-23
NO306235B1 (no) 1999-10-11
US5763452A (en) 1998-06-09

Similar Documents

Publication Publication Date Title
NO943511L (no) Farmasöytiske preparater og anvendelse derav
NO921012L (no) Farmasoeytiske preparater og deres anvendelse
NO305952B1 (no) 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
BR1100824A (pt) Composto e composição farmacêutica
NO305316B1 (no) Nye substituerte 1H-imidazoler og farmas°ytiske preparater inneholdende disse
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
BR1100329A (pt) Composto e formulação farmacêutica
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
NO961274D0 (no) Azolderivat og farmasöytiske preparat derav
DK0540609T3 (da) Cephalosporiner og homologer, fremstillinger og farmaceutiske præparater
DK130389D0 (da) Catecholderivater og farmaceutiske praeparater omfatende samme
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
NO973980D0 (no) Imiadazolderivater og medisinsk preparat
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
DK40292D0 (da) Dibenzofurancarboxamider og farmaceutiske praeparater indeholdende disse
NO985572D0 (no) Substituerte amidinobenzenderivater og medisinske preparater derav
NO305362B1 (no) Aryloksycykloalkenyl- og aryloksyiminocykloalkenylhydroksyurinstoffer og farmas°ytiske preparater inneholdende disse
NO922812D0 (no) Naftyridin- og kinolizinderivater og farmasoeytiske preparater inneholdende disse
NO922988L (no) Potensfremmende middel og fremstilling derav
NO921049D0 (no) Bakterieinhiberende preparat og anvendelse derav
BR1100809A (pt) Composto e composição farmacêutica

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees